Inato secures $14m investment for clinical trial matching platform

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Champc)
(Image: Getty/Champc)

Related tags: Inato

The Series A financing round arrives as the company suggests it is able to reduce the number of sites needed by a clinical trial by 29%.

Inato, based in Paris, France, possesses a platform that matches a clinical trial site with a sponsor, but in a fashion that increases the pool of available patients, the company suggests.

As a result of the offering, Obvious Ventures and Cathay Innovation joined previous backers, in Serena and Fly Ventures, to fund Inato to the tune of $14m (€12.7m).

Despite being the company’s first significant financing round, it has already aided the operations of over 50 global clinical trials across 2,000 research sites.

“Five percent of the world’s research sites are conducting the vast majority of today’s clinical trials. When you consider that the average cost of bringing a drug to market is around $2 billion, with about two-thirds of those costs tied to clinical trials, it’s clear there’s an urgent need for greater efficiency,”​ said Inato Co-Founder and CEO Kourosh Davarpanah.

Davarpanah continued to suggest Inato will work to bring doctors, and their patients, into its clinical research ‘ecosystem’.

The company will use the funds raised to improve its platform’s predictive capabilities, in matching sites with clinical trials, and to develop a global network of clinicians. Currently, Inato states that the product’s algorithm can help reduce the number of sites needed in a study by 29%.

In addition to Obvious Ventures’ investment, its managing director, Nan Li, will also join Inato’s board of directors.

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars